CAR T Cells Armed with IL-15 Show Promise in Solid Cancer Therapy
Scientists at Baylor College of Medicine and Texas Children’s Cancer Center led a first-in-human study of a novel immunotherapy approach for solid tumors expressing glypican-3 (GPC3). The team, which published its findings in an article titled, “ …